Suprachoroidal Injection of CLS-TA Alone or With Aflibercept in Subjects With Diabetic Macular Edema
Clinical trial NCT02949024 · COMPLETED
Trial details
- NCT number
- NCT02949024
- Sponsor
- Clearside Biomedical, Inc.
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2016-11-10
- Primary completion
- 2017-10-17
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.